HiPSC Facilty
Stem cell technology to create bespoke lab-grown brain cells to better understand disease mechanisms
Coming soon
Location: Queen Square House
Full service high-quality facility to open at Grays Inn Road in 2028
The human-induced pluripotent stem cell (iPSC) core can help with acquisition, expansion, banking and quality control of iPSC lines according to standardised protocols, in line with those recommended by the International Society for Stem Cell Research (ISSCR).
Custom projects, including reprogramming, iPSC differentiation into 2D and 3D cultures and gene-editing, will be available on a service or collaborative basis depending on capacity and researcher preferences, to be arranged by discussion.
The platform can also provide standardised protocols and training for individual researchers in iPSC culture methods.
Support for all aspects of iPSC culture, from reprogramming of patient lines and characterisation of iPSC to differentiation, phenotyping and genome editing.
Our Impact
Our researchers have access to remarkable stem cell technology, where researchers can turn ordinary cells – such as blood or skin cells – into brain cells. The process involves applying specific molecules and proteins to transform the cells. This allows scientists to grow living human brain cells – ‘mini brains in a dish’ – to study and understand disease mechanisms and to develop and test potential drug therapies.
A dedicated team
A dedicated technical team in place to support you
Cost-effective
Cost effectiveness through batch ordering of media and reagents
Best practice methods
Standardised protocols and quality control procedures ensuring the highest quality cell lines
Access to resources
Access to resources through cataloguing of iPSC available at Queen Square Institute of Neurology
Contact
